Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37950887.
- Also identified by DOI 10.1093/cid/ciad500 and PMC identifier 11959183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and mortality. Despite its prevalence, significant practice variation continues to permeate clinical management of this syndrome. Since the publication of the 2011 Infectious Diseases Society of America (IDSA) guidelines on management of methicillin-resistant Staphylococcus aureus infections, the field of SAB has evolved with the emergence of newer diagnostic strategies and therapeutic options. In this review, we seek to provide a comprehensive overview of the evaluation and management of SAB, with special focus on areas where the highest level of evidence is lacking to inform best practices.
Medical subject headings
- Methicillin-Resistant Staphylococcus aureus
- Staphylococcal Infections
- Bacteremia